Ingrid A.W. van Rijsingen

Author

Amsterdam UMC Location University of Amsterdam

Also Known As

I. A. W. Van Rijsingen, I. A. W. van Rijsingen, I.A.W. van Rijsingen, Ingrid A. W. van Rijsingen, Ingrid A.W. van Rijsingen, M. Richardson

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Amsterdam UMC Location University of Amsterdam University Medical Center Groningen University of Groningen Netherlands Heart Institute University of Amsterdam

About

Ingrid A.W. van Rijsingen is an author at Amsterdam UMC Location University of Amsterdam specializing in pathology, medicine, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	577
2	Public Health	2	2	51
3	Epidemiology	1	1	40
4	Exercise Physiology	1	1	11
5	Molecular Medicine	1	1	11

Ingrid A.W. van Rijsingen

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Risk Factors for Malignant Ventricular Arrhythmias in Lamin A/C Mutation Carriers Ingrid A.W. van Rijsingen, Eloisa Arbustini, Perry Elliott, Journal of the American College of Cardiology Cardiac MuscleCardiomyopathyHeart FailureCardiovascular DiseaseMalignant Ventricular Arrhythmias	2012	507
Phospholamban R14del Mutation in Patients Diagnosed with Dilated Cardiomyopathy or Arrhythmogenic Right Ventricular Cardiomyopathy: Evidence Supporting the Concept of Arrhythmogenic Cardiomyopathy Paul A. van der Zwaag, Ingrid A.W. van Rijsingen, Angeliki Asimaki, European Journal of Heart Failure	2012	452
Outcome in Phospholamban R14del Carriers Ingrid A.W. van Rijsingen, Paul A. van der Zwaag, Judith A. Groeneweg, Circulation Cardiovascular Genetics	2014	185
Truncating Titin Mutations are Associated with a Mild and Treatable form of Dilated Cardiomyopathy Joeri A. Jansweijer, Karin Nieuwhof, Francesco Paolo Russo, European Journal of Heart Failure	2016	170
Genetic Analysis in 418 Index Patients with Idiopathic Dilated Cardiomyopathy: Overview of 10 Years’ Experience Karin Y. van Spaendonck‐Zwarts, Ingrid A.W. van Rijsingen, Maarten P. van den Berg, European Journal of Heart Failure	2013	162
Gender-Specific Differences in Major Cardiac Events and Mortality in Lamin A/C Mutation Carriers Ingrid A.W. van Rijsingen, Eline A. Nannenberg, Eloisa Arbustini, European Journal of Heart Failure	2012	143
Recurrent and founder mutations in the Netherlands—Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy Paul A. van der Zwaag, Ingrid A.W. van Rijsingen, Roald Ruiter, Netherlands Heart Journal	2013	92
Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications Ingrid A.W. van Rijsingen, Annemieke Bakker, Donija Azim, International Journal of Cardiology Lamin A/c MutationThrombosisVascular DiseaseEpidemiologyVenous Thromboembolic Complications	2012	40
Hypertrophic cardiomyopathy family with double-heterozygous mutations; does disease severity suggest doubleheterozygosity? Ingrid A.W. van Rijsingen, J.F. Hermans-van Ast, Yvonne Arens, Netherlands Heart Journal CardiomyopathyMendelian DisorderCardiovascular DiseaseGenetic DisorderGenetics	2009	19
Effect of Ascertainment Bias on Estimates of Patient Mortality in Inherited Cardiac Diseases Eline A. Nannenberg, Ingrid A.W. van Rijsingen, Paul A. van der Zwaag, Circulation Genomic and Precision Medicine	2018	14

Page 1